Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
The Core
The Core
Activities:
Research & Development
Estates & Facilities
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Life sciences sector hit with funding cuts, but novel report highlights feasible industry solutions
The review highlights the recent investment reductions observed within the life sciences industry, and why its important to support smaller businesses to develop their innovations
Sanofi and Novavax co-commercialise COVID-19 vaccine
The agreement will aim to commercialise Novavax's adjuvanted COVID-19 vaccination globally, as well as develop a COVID-19 and flu combination vaccine
Realtime flowmeters provide full software connectivity to HPLC data system
The RC.net/ICF compatible software allows users to gather accurate and precise flow readings while using chromatography software packages
WestGene's mRNA therapeutic cancer vaccine receives FDA approval
The novel mRNA therapeutic is the first EB virus-related cancer vaccine to be approved by the FDA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Design & Build
Plans for a £20m lab facility in Newcastle upon Tyne approved
The laboratory will form part of Newcastle's science and business hub
Subscribe now